Extended Data Fig. 1: HCoV reactivity following two doses of SARS-CoV-2 vaccine. | Nature Microbiology

Extended Data Fig. 1: HCoV reactivity following two doses of SARS-CoV-2 vaccine.

From: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Extended Data Fig. 1: HCoV reactivity following two doses of SARS-CoV-2 vaccine.

Antibody responses were studied in three groups of individuals (n = 24 per group) vaccinated with either BNT162b2, ChAdOx1 or mRNA-1273 by MSD-ECL assay. Responses were measured against full-length spike glycoprotein (Spike) from HCoVs 229E, OC43, NL63 and HKU1 and are expressed as MSD arbitrary units (AU/ml). The response to OC43 was significantly higher in BNT162b2 vaccinates than in ChAdOx1 vaccinates. Bar represents group mean. Group means compared by one-way ANOVA, Tukey’s multiple comparisons test, **** significantly different p < 0.0001.

Source data

Back to article page